Prescription drug · NDA
Vyzulta (Latanoprostene bunod) NDC 24208-504
Latanoprostene bunod .24 mg/mL · Solution/ drops · Ophthalmic · Bausch & Lomb Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24208-504-01 | 2420805040124208050401 | 1 BOTTLE in 1 CARTON (24208-504-01) / 2.5 mL in 1 BOTTLEMarketed from Jun 11, 2018 · Sample package | |
| 24208-504-02 | 2420805040224208050402 | 1 BOTTLE in 1 CARTON (24208-504-02) / 2.5 mL in 1 BOTTLEMarketed from Jun 11, 2018 | |
| 24208-504-05 | 2420805040524208050405 | 1 BOTTLE in 1 CARTON (24208-504-05) / 5 mL in 1 BOTTLEMarketed from Nov 2, 2017 | |
| 24208-504-06 | 2420805040624208050406 | 1 BOTTLE in 1 CARTON (24208-504-06) / 5 mL in 1 BOTTLEMarketed from Nov 2, 2017 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vyzulta
- Generic name (nonproprietary)
- latanoprostene bunod
- Active ingredients
- Latanoprostene bunod — .24 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Bausch & Lomb IncorporatedNDC labeler code 24208
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 207795
- Marketing start
- Listing expires
- Identifiers
- Product ID 24208-504_12648511-1ae2-aaf8-e063-6394a90a2297SPL ID 12648511-1ae2-aaf8-e063-6394a90a2297SPL set ID 60ce7900-a677-4fc2-88d0-1603baa9dbd4RxCUI 1988394, 1988399UNII I6393O0922
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424208050401followed by a unit qualifier and the quantityPackage 24208-0504-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. VYZULTA is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 24208-504
- What is NDC 24208-504?
- 24208-504 is the product NDC for Vyzulta (latanoprostene bunod), Latanoprostene bunod .24 mg/mL solution/ drops, listed with the FDA by Bausch & Lomb Incorporated. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Vyzulta (Latanoprostene bunod).
- What is the active ingredient?
- Latanoprostene bunod.
- Who is the labeler?
- Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Vyzulta?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.